TGF-β1 variants in chronic beryllium disease and sarcoidosis

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 4255-4262

  Jonth, Alexas C ^a   Silveira, Lori ^a,b   Fingerlin, Tasha E ^b   Sato, Hiroe ^a,c   Luby, Julie C ^a   Welsh, Kenneth I ^c   Rose, Cecile S ^a,b   Newman, Lee S ^b,d   Du Bois, Roland M ^a,c   Maier, Lisa A ^a,b,d   Weinberger, Steven E ^e   Finn, Patricia ^e   Garpestad, Erik ^e   Moran, Allison ^e   Yeager Jr , Henry ^f   Rabin, David L ^f   Stein, Susan ^f   Iannuzzi, Michael C ^g   Rybicki, Benjamin A ^g   Major, Marcie ^g   Maliarik, Mary ^g   Popovich Jr , John ^g   Moller, David R ^h   Johns, Carol J ^h   Rand, Cynthia ^h   Steimel, Joanne ^h   Judson, Marc A ⁱ   D'Alessandro, Susan ⁱ   Heister, Nancy ⁱ   Johnson, Theresa ⁱ   Lackland, Daniel T ⁱ   Pandey, Janardan ⁱ   Sahn, Steven ⁱ   Strange, Charlie ⁱ   Teirstein, Alvin S ^j   DePalo, Louis ^j   Brown, Sheldon ^j   Lesser, Marvin ^j   Padilla, Maria L ^j   Marshall, Marilyn ^j   Rose, Cecile ^d   Barnard, Juliana ^d   Martyny, John ^d   McCammon, Charles ^d   Baughman, Robert P ^k   Lower, Elyse E ^k   Winget, Donna B ^k   McLennan, Geoffrey ^l   Hunninghake, Gary ^l   Dayton, Chuck ^l   Powers, Linda ^l   Rossman, Milton D ^m   Bresnitz, Eddy A ^m   Daniele, Ronald ^m   Regovich, Jackie ^m   Sexauer, William ^m   Musson, Robert ⁿ   Deshler, Joanne ⁿ   Sorlie, Paul ⁿ   Wu, Margaret ⁿ   Cherniack, Reuben ^r   Newman, Lee ^r   Knatterud, Genell L ^o   Terrin, Michael L ^o   Thompson, Bruce W ^o   Brown, Kathleen ^o   Frederick, Margaret ^o   LoPresti, Frances ^o   Wilkins, Patricia ^o   Canner, Martha ^o   Dotson, Judy ^o   Lindenfelser, Steve ^p   Cosentino, Mark ^q   more..

^a Div Environ and Occup Hlth Sci   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j MOUNT SINAI MEDICAL CENTER   (United States)

^k UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^l UNIVERSITY OF IOWA   (United States)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^o Clinical Trials & Surveys Corp   (United States)

^p McKesson   (United States)

^q BBI Biotech Research Laboratories   (United States)

^r BBI Biotech Research Laboratories ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; BERYLLIUM;

ADULT; ARTICLE; BERYLLIOSIS; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOIDOSIS; CASE CONTROL STUDY; CLINICAL TRIAL; CODON; COMPARATIVE STUDY; GENETICS; GENOTYPE; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR;

ADULT; BERYLLIOSIS; BERYLLIUM; CASE-CONTROL STUDIES; CHRONIC DISEASE; CODON; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1; VARIATION (GENETICS);

EID: 35748934788     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.4255     Document Type: Article

References (44)

1. + T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. USA 97: 12717-12722.
2. Maier, L. A., D. S. McGrath, H. Sato, P. Lympany, K. Welsh, R. Du Bois, L. Silveira, A. P. Fontenot, R. T. Sawyer, E. Wilcox, and L. S. Newman. 2003. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J. Immunol. 171: 6910-6918.
3. Newman, L. S., C. S. Rose, and L. A. Maier. 1997. Medical progress: sarcoidosis. N. Engl. J. Med. 336: 1224-1234.
4. Rossman, M. D., B. Thompson, M. Frederick, M. Maliarik, M. C. Iannuzzi, B. A. Rybicki, J. P. Pandey, L. S. Newman, E. Magira, B. Beznik-Cizman, and D. Monos. 2003. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73: 720-735.
5. Sato, H., J. C. Grutters, P. Pantelidis, A. N. Mizzon, T. Ahmad, A. J. Van Houte, J. W. Lammers, J. M. Van Den Bosch, K. I. Welsh, and R. M. Du Bois. 2002. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir. Cell. Mol. Biol. 27: 406-412.
6. Rybicki, B. A., M. J. Maliarik, L. M. Poisson, R. Sheffer, K. M. Chen, M. Major, G. A. Chase, and M. C. Iannuzzi. 2003. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am. J. Respir. Crit. Care Med. 167: 444-449.
7. Grunewald, J., M. Berlin, O. Olerup, and A. Eklund. 2000. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 161: 814-818.
8. + T cell expansions in sarcoidosis patients with a shared HLA-DRβ chain conformation. Thorax 57: 348-352.
9. Forrester, J. M., L. S. Newman, T. E. King, Jr., and B. L. Kotzin. 1993. Clonal expansion of lung Vd1 T-cells in a subset of patients with sarcoidosis. J. Clin. Invest. 91: 292-300.
10. Cambien, F., S. Ricard, A. Troesch, C. Mallet, L. Generenaz, A. Evans, D. Arveiler, G. Luc, J. B. Ruidavets, and O. Poirier. 1996. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28: 881-887.
11. Grainger, D. J., K. Heathcote, M. Chiano, H. Snieder, P. R. Kemp, J. C. Metcalfe, N. D. Carter, and T. D. Spector. 1999. Genetic control of the circulating concentration of transforming growth factor type β1. Hum. Mol. Genet. 8: 93-97.
12. Yamada, Y., A. Miyauchi, J. Goto, Y. Takagi, H. Okuizumi, M. Kanematsu, M. Hase, H. Takai, A. Harada, and K. Ikeda. 1998. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J. Bone Miner. Res. 13: 1569-1576.
13. Awad, M. R., A. El-Gamel, P. Hasleton, D. M. Turner, P. J. Sinnott, and I. V. Hutchinson. 1998. Genotypic variation in the transforming growth factor-β1 gene: association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66: 1014-1020.
14. Limper, A. H., T. V. Colby, M. S. Sanders, S. Asakura, P. C. Roche, and R. A. DeRemee. 1994. Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 149: 197-204.
15. Rossman, M. D., J. Stubbs, C. W. Lee, E. Argyris, E. Magira, and D. Monos. 2002. Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am. J. Respir. Crit. Care Med. 165: 788-794.
16. 1999. Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med. 160: 736-755.
17. ACCESS Research Group. 1999. Design of a case control etiologic study of sarcoidosis (ACCESS). J. Clin. Epidemiol. 52: 1173-1186.
18. Ogilvie, C. M., R. E. Forster, W. S. Blakemore, and J. W. Morton. 1956. A standardized breathholding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J. Clin. Invest. 36: 1-17.
19. Lundgren, R. A., L. A. Maier, C. S. Rose, R. C. Balkissoon, and L. S. Newman. 2001. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest 120: 1702-1708.
20. Daniloff, E. M., D. A. Lynch, B. Bucher Bartelson, J. D. Newell, Jr., S. M. Bernstein, and L. S. Newman. 1997. Observer variation and relationship of computed tomography to severity of beryllium disease. Am. J. Respir. Crit. Care Med. 155: 2047-2056.
21. Maier, L. A., E. A. Barker, M. V. Raynolds, and L. S. Newman. 1999. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 159: 1342-1350.
22. Baughman, R. P., A. S. Teirstein, M. A. Judson, M. D. Rossman, H. Yeager, Jr., E. A. Bresnitz, L. DePalo, G. Hunninghake, M. C. Iannuzzi, C. J. Johns, et al. 2001. Clinical characteristics of patients in a case control study of sarcoidosis. Am. J. Respir. Crit. Care Med. 164: 1885-1889.
23. Bunce, M., C. M. O'Neill, M. C. Barnardo, P. Krausa, M. J. Browning, P. J. Morris, and K. I. Welsh. 1995. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes using sequence-specific primers (PCR-SSP). Tissue Antigens 46: 355-367.
24. Lympany, P. A., J. J. Avila, C. Mullighan, S. Marshall, K. I. Welsh, and R. M. du Bois. 1998. Rapid genotyping of transforming growth factor β1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 52: 573-578.
25. Gabriel, S. B., S. F. Schaffner, H. Nguyen, J. M. Moore, J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochner, M. Faggart, et al. 2002. The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
26. Schaid, D. J., C. M. Rowland, D. E. Tines, R. M. Jacobson, and G. A. Poland. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70: 425-434.
27. Mana, J., and F. Badrinas. 1992. Prognosis of sarcoidosis: an unresolved issue. Sarcoidosis 9: 15-20.
28. Drumm, M. L., M. W. Konstan, M. D. Schluchter, A. Handler, R. Pace, F. Zou, M. Zariwala, D. Fargo, A. Xu, J. M. Dunn, et al. 2005. Genetic modifiers of lung disease in cystic fibrosis. N. Engl. J. Med. 353: 1443-1453.
29. Xaubet, A., A. Marin-Arguedas, S. Lario, J. Ancochea, F. Morell, J. Ruiz-Manzano, E. Rodriguez-Becerra, J. M. Rodriguez-Arias, P. Inigo, S. Sanz, et al. 2003. Transforming growth factor-β1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 168: 431-435.
30. Newman, L. S., C. S. Rose, E. A. Bresnitz, M. D. Rossman, J. Barnard, M. Frederick, M. L. Terrin, S. E. Weinberger, D. R. Moller, G. McLennan, et al. 2004. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am. J. Respir. Crit. Care Med. 170: 1324-1330.
31. Wu, L., J. Chau, R. P. Young, V. Pokorny, G. D. Mills, R. Hopkins, L. McLean, and P. N. Black. 2004. Transforming growth factor-β1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 59: 126-129.
32. Celedon, J. C., C. Lange, B. A. Raby, A. A. Litonjua, L. J. Palmer, D. L. DeMeo, J. J. Reilly, D. J. Kwiatkowski, H. A. Chapman, N. Laird, et al. 2004. The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum. Mol. Genet. 13: 1649-1656.
33. Silverman, E. S., L. J. Palmer, V. Subramaniam, A. Hallock, S. Mathew, J. Vallone, D. S. Faffe, T. Shikanai, B. A. Raby, S. T. Weiss, and S. A. Shore. 2004. Transforming growth factor-β1 promoter polymorphism C-509T is associated with asthma. Am. J. Respir. Crit. Care Med. 169: 214-219.
34. + T cells is facilitated by CTLA-4 signaling. J. Immunol. 177: 2331-2339.
35. Gorelik, L., and R. A. Flavell. 2002. Transforming growth factor-β in T-cell biology. Nat. Rev. Immunol. 2: 46-53.
36. Wahl, S. M., J. Swisher, N. McCartney-Francis, and W. Chen. 2004. TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells. J. Leukocyte Biol. 76: 15-24.
37. Miyara, M., Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, M. Kambouchner, D. Valeyre, C. Chapelon-Abric, P. Debre, et al. 2006. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203: 359-370.
38. Zissel, G., J. Homolka, J. Schlaak, M. Schlaak, and J. Muller-Quernheim. 1996. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 154: 713-719.
39. McCartney-Francis, N. L., and S. M. Wahl. 1994. Transforming growth factor β: a matter of life and death. J. Leukocyte Biol. 55: 401-409.
40. Meng, J., T. Thongngarm, M. Nakajima, N. Yamashita, K. Ohta, C. A. Bates, G. K. Grunwald, and L. J. Rosenwasser. 2005. Association of transforming growth factor-β1 single nucleotide polymorphism C-509T with allergy and immunological activities. Int. Arch. Allergy Immunol. 138: 151-160.
41. Gaede, K. I., M. Amicosante, M. Schurmann, E. Fireman, C. Saltini, and J. Muller-Quernheim. 2005. Function associated transforming growth factor-β gene polymorphism in chronic beryllium disease. J. Mol. Med. 83: 397-405.
42. Kruit, A., J. C. Grutters, H. J. Ruven, C. H. van Moorsel, R. Weiskirchen, S. Mengsteab, and J. M. van den Bosch. 2006. Transforming growth factor-β gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 129: 1584-1591.
43. Niimi, T., S. Sato, Y. Sugiura, T. Yoshinouchi, K. Akita, H. Maeda, H. Achiwa, S. Ninomiya, Y. Akita, M. Suzuki, et al. 2002. Transforming growth factor-β gene polymorphism in sarcoidosis and tuberculosis patients. Int. J. Tuberc. Lung Dis. 6: 510-515.
44. Murakozy, G., K. I. Gaede, G. Zissel, M. Schlaak, and J. Muller-Quernheim. 2001. Analysis of gene polymorphisms in interleukin-10 and transforming growth factor-β 1 in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 18: 165-169.